In today's episode, we speak with Dr Emiel Michiels, Entrepreneur in Residence at VIB in Belgium. He discusses his journey to found a company and the translation of his academic research on protein aggregation to practical therapeutic use.

Protein aggregation diseases occur when clumps of protein are deposited in specific organs. Two of the most widely known are Alzheimer's and Parkinson's Disease, caused by protein aggregation in the brain, but there are several rarer diseases caused by a similar phenomenon. Emiel's future company aims to investigate if its technology can impact these aggregates and create a beneficial effect for patients.